ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,596Medicare Part D Prescriptions Filled, Including Refills

Rank: 411 out of 2061

$559K Total Retail Price of All Prescriptions

Rank: 561 out of 2061

340 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 340 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 340 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,597 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 466 432 1 1
METOPROLOL TARTRATE 423 415 2 7
LEVOTHYROXINE SODIUM 412 370 3 3
FUROSEMIDE 379 364 4 6
OMEPRAZOLE 343 321 5 5
LISINOPRIL 291 275 6 2
AMLODIPINE BESYLATE 260 248 7 4
HYDROCODONE-ACETAMINOPHEN 218 167 S3 8 10
WARFARIN SODIUM 183 182 9 11
NAMENDA 177 170 10 37
MIRTAZAPINE 174 161 11 46
LOSARTAN POTASSIUM 157 157 12 17
DONEPEZIL HCL 156 154 13 24
CITALOPRAM HBR 155 145 14 20
GABAPENTIN 154 128 15 15
TAMSULOSIN HCL 144 131 16 30
SPIRONOLACTONE 136 128 17 62
METFORMIN HCL 134 124 18 9
POTASSIUM CHLORIDE 125 110 19 16
HYDROCHLOROTHIAZIDE 124 115 20 12
PRAVASTATIN SODIUM 116 101 21 14
FINASTERIDE 115 102 22 86
TRAMADOL HCL 112 94 23 18
ATORVASTATIN CALCIUM 107 105 24 8
DIOVAN 102 102 25 41
ATENOLOL 99 99 26 13
METOPROLOL SUCCINATE 93 89 27 19
TRAZODONE HCL 93 81 27 39
FENOFIBRATE 91 80 29 65
ALLOPURINOL 90 88 30 28
RISPERIDONE 87 87 31 66
CYMBALTA 84 80 32 59
ALENDRONATE SODIUM 78 64 33 25
ADVAIR DISKUS 77 77 34 57
ISOSORBIDE MONONITRATE ER 77 65 34 42
QUETIAPINE FUMARATE 74 74 36 72
HYDRALAZINE HCL 68 46 37 69
LANTUS 66 39 38 48
KLOR-CON M20 65 51 39 47
BYSTOLIC 65 43 39 130
OXYBUTYNIN CHLORIDE ER 63 49 41 80
CLOPIDOGREL 62 62 42 29
CARVEDILOL 60 36 43 22
FENTANYL 59 59 S2 44 84
ESCITALOPRAM OXALATE 59 49 44 77
DIVALPROEX SODIUM 59 59 44 74
ZOLPIDEM TARTRATE 58 54 47 23
ALBUTEROL SULFATE 58 58 47 104
NOVOLOG 57 27 49 102
ENABLEX 51 51 50 256
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.